Data Integrity Considerations in Risk-Based Decision-Making
In pharmaceutical manufacturing, data integrity is foundational—not optional. With the adoption of risk-based approaches in stability testing and broader quality systems, it’s critical to ensure that decisions are driven by reliable, traceable, and accurate data. Regulatory agencies including the USFDA and CDSCO have issued stern warnings when companies rely on questionable data to justify bracketing,…
Read More “Data Integrity Considerations in Risk-Based Decision-Making” »